Ovarian Cancer Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Drug, Biomarker, Cancer Diagnostic, Clinical Trial.


 
1-10 of 22 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

Ovarian Cancer Partnering 2010-2015

Ovarian Cancer Partnering 2010-2015

  • $ 995
  • Industry report
  • March 2015
  • by Currentpartnering

The Ovarian Cancer Partnering 2010-2015 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Ovarian Cancer Drug Pathway Analyzer 2015

Ovarian Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 349 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

Ovarian Cancer Drug Pipeline Update 2015

Ovarian Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

 Ovarian Cancer-API Insights, 2014

Ovarian Cancer-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numbe ...

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report ...

Metastatic Ovarian Cancer - Pipeline Review, H2 2014

Metastatic Ovarian Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Metastatic Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Ovarian Cancer’s ...

 Metastatic Ovarian Cancer-Pipeline Insights, 2014

Metastatic Ovarian Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“ Metastatic Ovarian Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

 Epithelial Ovarian Cancer-Pipeline Insights, 2014

Epithelial Ovarian Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“ Epithelial Ovarian Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

About 2 500 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • January 2013
    123 pages
  • Ovarian Cancer  

    Oncology  

    Chemotherapy  

  • United Kingdom  

View report >

Pathology Description

December 2013

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.